Key Highlights: Implications: Sun ignites generics price war against Novo/Eli Lilly premium brands, slashing obesity therapy costs and exploding Tier-2/3 access. Dual T2D/weight...
Key Highlights: Implications: India’s pet care market reaches $3.6B in 2024, growing 20% CAGR to $24.8B by 2032; veterinary healthcare hits $1.76B by 2026 (8.64% CAGR)—partnership ta...
Key Highlights: Implications: Jubilant catapults into top-tier CRO/CDMO contender, snatching complex molecule work from Lonza/Capricor as India chemistry talent goes global. Noid...
Key Highlights: Implications: The appointment underlines ChemWerth’s intent to treat India not just as a sourcing base but as a strategic growth market for its re...
Key Highlights: Implications: Lantern’s Bengaluru expansion accelerates U.S. biotech offshoring of AI-drug discovery to India, intensifying talent competition with Dr. Reddy’s and Biocon w...
Key Highlights: Implications: Dr. Reddy’s grabs monopoly control over Hepatitis E prevention, dominating public health tenders and private vaccination drives as awareness explo...
Key Highlights: Implications: PrecisionCHD taps India’s $1.5B+ cardiac diagnostics market (15% CAGR), challenging ECG/stress tests via molecular insights and Dr Lal’s netw...
Key Highlights: Implications: The large-scale Daisy Petal deployment at Serum Institute signals a meaningful shift from traditional fed-batch to perfusion-based biomanufacturing in v...
